Evidence map›Paper›PMID 40733034›Full record

ArticlePharmaceutics2025

Palmitoylation Transduces the Regulation of Epidermal Growth Factor to Organic Anion Transporter 3.

Zhou Yu, Jinghui Zhang, Jiaxu Feng, Guofeng You

Abstract read
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Roles of ProteinCancer communications (London, England) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhou YuDepartment of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Jinghui ZhangDepartment of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Jiaxu FengDepartment of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.ORCID 0009-0008-8239-8062
Guofeng YouDepartment of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

Funding

Sumoylation: A Novel Mechanism for Regulating Drug/Xenobiotic Transporters OATsR01GM097000 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI YOU, GUOFENG · 2012 to 2020
$2.4M
Trafficking and Regulation of Drug/Xenobiotic Transporter OATR01GM079123 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI YOU, GUOFENG · 2008 to 2017
$2.2M
New Targets for Regulating Drug/Xenobiotic Transporter OATR01GM127788 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI YOU, GUOFENG · 2018 to 2021
$1.2M
New Jersey Health Foundation PC122-25NIGMS NIH HHS R01 GM079123NIGMS NIH HHS R01-GM079123NIGMS NIH HHS R01 GM097000NIGMS NIH HHS R01-GM097000NIGMS NIH HHS R01 GM127788NIGMS NIH HHS R01-GM127788
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

epidermal growth factororganic anion transporter 3palmitoylationprotein kinase Aregulationsignaling pathwaytransporter

Identifiers

PMID40733034
PMCPMC12300882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.